Local Delivery of Enoxaparin to Decrease Restenosis After Stenting: Results of Initial Multicenter Trial

Abstract

This is the first prospective randomized trial in which the local delivery of a drug, enoxaparin, resulted in significant reduction in late luminal loss and restenosis after stent implantation in de novo coronary lesions.